CANAKINUMAB

10910 reported adverse events

These side effects are most commonly reported by patients taking CANAKINUMAB:

# Side effect Count
0 PYREXIA 1442
1 DRUG INEFFECTIVE 1242
2 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1242
3 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 966
4 PAIN 946
5 CONDITION AGGRAVATED 876
6 OFF LABEL USE 751
7 MALAISE 731
8 ARTHRALGIA 613
9 RASH 571
See all common reactions for CANAKINUMAB

CANAKINUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MUCKLE-WELLS SYNDROME 40 0.8163
1 X-LINKED LYMPHOPROLIFERATIVE SYNDROME 24 0.7273
2 ACTINOMYCOTIC SEPSIS 17 0.6800
3 CRYOPYRIN ASSOCIATED PERIODIC SYNDROME 108 0.5510
4 TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME 27 0.4500
5 FAMILIAL MEDITERRANEAN FEVER 82 0.4184
6 SERUM AMYLOID A PROTEIN INCREASED 53 0.3419
7 AUTOINFLAMMATORY DISEASE 47 0.2217
8 INTESTINAL SEPSIS 50 0.1908
9 SHORT STATURE 49 0.1870
See all enriched reactions for CANAKINUMAB